Joel Habener

Joel Habener
Alma mater
OccupationEndocrinologist Edit this on Wikidata
Awards

Joel Habener is a Professor of Medicine at Harvard Medical School and an Associate Physician at the Massachusetts General Hospital.[1]

Habener worked with Svetlana Mojsov on elucidating the role of incretin hormones such as glucagon-like peptide-1 (GLP-1) and glucagon-like peptide-2 (GLP-2). Habener received credit for the work on hormones when Mosjov was not credited.[2] Habener was awarded the 2020 Warren Alpert Foundation Prize along with Daniel Drucker and Jens Juul Holst.[3] He was elected to the National Academy of Sciences in 2020.[4] In 2021, he was awarded the Canada Gairdner International Award.[5] In 2023, he received the VinFuture Prize.[6] In 2024, he was awarded the Princess of Asturias Awards for Technical and Scientific Research,[7] the Tang Prize in the category of "Biopharmaceutical Science"[8] and also in 2024 the Lasker Award[9][10] for clinical research.

References

  1. ^ "Joel Habener, M.D. | Mass General Research Institute". Find a Researcher - Massachusetts General Hospital. Retrieved 2025-01-09.
  2. ^ Molteni, Megan; Chen, Elaine (27 September 2023). "The Ozempic revolution is rooted in the work of Svetlana Mojsov, yet she's been edged out of the story". STAT. Retrieved 2023-10-09.
  3. ^ "Prize Recipients | Warren Alpert Foundation Prize". warrenalpert.org.
  4. ^ "2020 NAS Election". www.nasonline.org.
  5. ^ Canada Gairdner International Award 2021
  6. ^ Nhu, Quynh (21 December 2023). "Battery researchers win $3M Vietnamese awards". VnExpress.
  7. ^ Princess of Asturias Awards 2024
  8. ^ Tang Prize 2024
  9. ^ Albert Lasker Award for Clinical Research
  10. ^ Prashant Nair (19 September 2024). "QnAs with Svetlana Mojsov, Joel Habener, and Lotte Bjerre Knudsen: Winners of the 2024 Lasker~DeBakey Clinical Medical Research Award". Proceedings of the National Academy of Sciences of the United States of America. 121 (39). doi:10.1073/PNAS.2416868121. ISSN 0027-8424. Wikidata Q130375905.